Abstract
Misleading terminology and arbitrary divisions stymie drug trials and can give false hope about the potential of tailoring drugs to individuals, warns Stephen Senn. [Figure not available: see fulltext.].
Original language | English |
---|---|
Pages (from-to) | 619-621 |
Number of pages | 3 |
Journal | Nature |
Volume | 563 |
Issue number | 7733 |
DOIs |
|
Publication status | Published - 29 Nov 2018 |
Keywords
- Medical research
- Personalized medicine